Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are expecting strong performance driven by the strong https://craigwmfi665929.webdesign96.com/37393132/eli-lilly-stock-a-deep-dive-into-q3-earnings